Cell line name NCC-TGCT1-C1
Accession CVCL_A9YZ
Resource Identification Initiative To cite this cell line use: NCC-TGCT1-C1 (RRID:CVCL_A9YZ)
Comments Part of: NCC sarcoma cell line panel.
Population: Japanese.
Doubling time: 30 hours (PubMed=32886306).
Derived from site: In situ; Hip, tendon sheath; UBERON=UBERON_0001486+UBERON_0000304.
Sequence variations
Gene fusion; HGNC; 2213; COL6A3 + HGNC; 2432; CSF1; Name(s)=COL6A3-CSF1 (PubMed=32886306).
Disease Malignant tenosynovial giant cell tumor (NCIt: C6535)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 40Y
Category Cancer cell line
STR profile

Source(s): PubMed=32886306


Amelogenin X
CSF1PO 11,13
D5S818 12
D7S820 9,12
D13S317 8,9
D16S539 9,12
D21S11 30,31.2
TH01 7
TPOX 8,11
vWA 14,17

PubMed=32886306; DOI=10.1007/s13577-020-00425-8
Noguchi R., Yoshimatsu Y., Ono T., Sei A., Hirabayashi K., Ozawa I., Kikuta K., Kondo T.
Establishment and characterization of a novel cell line, NCC-TGCT1-C1, derived from a patient with tenosynovial giant cell tumor.
Hum. Cell 34:254-259(2021)

Encyclopedic resources Wikidata; Q102114581

Additional information

User Category

Academia/non-profit organization, For-profit organization


There are no reviews yet.

Be the first to review “NCC-TGCT1-C1”

Your email address will not be published. Required fields are marked *